Millipore Sigma Vibrant Logo

05-23-3800 Endothelin 1, Human and Porcine - CAS 117399-94-7 - Calbiochem

概述

Replacement Information

重要规格表

CAS #Empirical Formula
117399-94-7C₁₀₉H₁₅₉N₂₅O₃₂S₅

价格及供货情况

产品目录编号 库存情况包装 数量 / 包装 价格 数量
05-23-3800-0.1MGCN
正在查询供货情况......
目前缺货
目前缺货
有货 
停产
少量现货
供货情况有待确认
    其余:另行通知
      其余:另行通知
      另行通知
      联系客户服务
      Contact Customer Service

      塑胶安瓿;塑胶针药瓶 .1 mg
      正在检索价格......
      无法检索价格。
      最小订购数量为倍数
      Maximum Quantity is
      以订单确认为准 更多信息
      您节约了 ()。
       
      Request Pricing
      05-23-3800-0.5MGCN
      正在查询供货情况......
      目前缺货
目前缺货
      有货 
      停产
      少量现货
      供货情况有待确认
        其余:另行通知
          其余:另行通知
          另行通知
          联系客户服务
          Contact Customer Service

          塑胶安瓿;塑胶针药瓶 .5 mg
          正在检索价格......
          无法检索价格。
          最小订购数量为倍数
          Maximum Quantity is
          以订单确认为准 更多信息
          您节约了 ()。
           
          Request Pricing
          Description
          OverviewA 21-amino acid polypeptide with potent vasoconstrictive action. Produces convulsions, arterial hypertension, and metabolic activation of periventricular white and gray matter. Its effects are mediated via L-type Ca2+ channels. Reported to activate phospholipase C in fibroblasts expressing ETA receptors.
          Catalogue Number05-23-3800
          Brand Family Calbiochem®
          SynonymsET-1, CSCSSLMDKECVYFCHLDIIW
          References
          ReferencesCesari, M., et al. 1996. Am. Heart J. 132, 1236.
          Gresser, O., et al 1996. Biochem. Biophys. Res. Commun. 224, 169.
          Murata, S., et al. 1995. J. Pharmacol. Exp. Ther. 274, 1524.
          Hexum, T.D., et al. 1990. Biochem. Biophys. Res. Commun. 167, 294.
          Itoh, Y., et al. 1988. FEBS Lett. 231, 440.
          Yanagisawa, M., et al. 1988. Nature 332, 411.
          Product Information
          CAS number117399-94-7
          ATP CompetitiveN
          FormWhite to off-white solid
          FormulationSupplied as an acetate salt.
          Hill FormulaC₁₀₉H₁₅₉N₂₅O₃₂S₅
          Chemical formulaC₁₀₉H₁₅₉N₂₅O₃₂S₅
          ReversibleN
          Sold on the basis of peptide contentY
          Quality LevelMQ100
          Applications
          Biological Information
          Primary TargetPotent vasoconstrictive action
          Purity≥96% by HPLC
          Physicochemical Information
          Cell permeableN
          Peptide ContentY
          Peptide SequenceH-Cys¹-Ser-Cys³-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys¹¹-Val-Tyr-Phe-Cys¹⁵-His-Leu-Asp-Ile-Ile-Trp-OH (disulfide bonds: 1 → 15; 3 → 11)
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Standard Handling
          Storage -20°C
          Protect from Moisture Protect from moisture
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 weeks at -20°C.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications
          Global Trade Item Number
          产品目录编号 GTIN
          05-23-3800-0.1MGCN 04055977226775
          05-23-3800-0.5MGCN 04055977226782

          Documentation

          Endothelin 1, Human and Porcine - CAS 117399-94-7 - Calbiochem MSDS

          职位

          物料安全数据表 (MSDS) 

          Endothelin 1, Human and Porcine - CAS 117399-94-7 - Calbiochem 分析证书

          标题批号
          05-23-3800

          参考

          参考信息概述
          Cesari, M., et al. 1996. Am. Heart J. 132, 1236.
          Gresser, O., et al 1996. Biochem. Biophys. Res. Commun. 224, 169.
          Murata, S., et al. 1995. J. Pharmacol. Exp. Ther. 274, 1524.
          Hexum, T.D., et al. 1990. Biochem. Biophys. Res. Commun. 167, 294.
          Itoh, Y., et al. 1988. FEBS Lett. 231, 440.
          Yanagisawa, M., et al. 1988. Nature 332, 411.
          数据表

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision12-May-2008 JSW
          SynonymsET-1, CSCSSLMDKECVYFCHLDIIW
          DescriptionA 21 amino acid polypeptide with potent vasoconstrictive action. Produces convulsions, arterial hypertension, and metabolic activation of periventricular white and gray matter. Its effects are mediated via L-type Ca2+ channels. Reported to activate phospholipase C in fibroblasts expressing ETA receptors.
          FormWhite to off-white solid
          FormulationSupplied as an acetate salt.
          CAS number117399-94-7
          Chemical formulaC₁₀₉H₁₅₉N₂₅O₃₂S₅
          Peptide SequenceH-Cys¹-Ser-Cys³-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys¹¹-Val-Tyr-Phe-Cys¹⁵-His-Leu-Asp-Ile-Ile-Trp-OH (disulfide bonds: 1 → 15; 3 → 11)
          Purity≥96% by HPLC
          Solubility5% Acetic acid (0.5 mg/ml). Dissolve peptide initially at 8 mg/ml in 80% cold acetic acid, then dilute with distilled water to achieve 5% acetic acid and 0.5 mg/ml peptide.
          Storage Protect from moisture
          -20°C
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 weeks at -20°C.
          Toxicity Standard Handling
          ReferencesCesari, M., et al. 1996. Am. Heart J. 132, 1236.
          Gresser, O., et al 1996. Biochem. Biophys. Res. Commun. 224, 169.
          Murata, S., et al. 1995. J. Pharmacol. Exp. Ther. 274, 1524.
          Hexum, T.D., et al. 1990. Biochem. Biophys. Res. Commun. 167, 294.
          Itoh, Y., et al. 1988. FEBS Lett. 231, 440.
          Yanagisawa, M., et al. 1988. Nature 332, 411.